HDL as a prognostic biomarker for coronary atherosclerosis: the role of inflammation
- PMID: 26854521
- DOI: 10.1517/14728222.2016.1152264
HDL as a prognostic biomarker for coronary atherosclerosis: the role of inflammation
Abstract
Introduction: Emerging evidence suggests that the role of high density lipoprotein (HDL) in the atherosclerotic process is not as clear as previously thought, since atheroprotective HDL becomes atherogenic in states of increased inflammatory processes.
Areas covered: In this review we aim to elucidate the role of HDL as a prognostic biomarker and we discuss therapeutic approaches that aim to increase HDL and their possible clinical benefit.
Expert opinion: Given the structural variability and biological complexity of the HDL particle, its role in the atherosclerotic process is far from clear. According to current evidence, the atheroprotective role of HDL turns atherogenic in states of increased inflammatory processes, while even minor alterations in systemic inflammation are likely to hinder the endothelial protective effects of HDL. In accordance, significant data have revealed that HDL-related drugs may be effective in reducing cardiovascular mortality; however they are not as encouraging or unanimous as expected. Possible future goals could be to quantify either HDL subclasses or functions in an attempt to reach safer conclusions as to the prognostic importance of HDL in coronary atherosclerosis. Having achieved that, a more targeted therapy that would aim to raise either HDL functionality or to remodel HDL structure would be more easily designed.
Keywords: High density lipoprotein; atherosclerosis; inflammation; treatment.
Similar articles
-
High-density lipoproteins as modulators of endothelial cell functions: alterations in patients with coronary artery disease.Cardiovasc Res. 2014 Aug 1;103(3):350-61. doi: 10.1093/cvr/cvu139. Epub 2014 Jun 15. Cardiovasc Res. 2014. PMID: 24935432 Review.
-
Atheroprotective effects of high-density lipoprotein-associated lysosphingolipids.Trends Cardiovasc Med. 2005 Oct;15(7):265-71. doi: 10.1016/j.tcm.2005.08.005. Trends Cardiovasc Med. 2005. PMID: 16226682 Review.
-
High-density lipoprotein metabolism and progression of atherosclerosis: new insights from the HDL Atherosclerosis Treatment Study.Curr Opin Cardiol. 2004 Jul;19(4):385-91. doi: 10.1097/01.hco.0000126979.41946.7e. Curr Opin Cardiol. 2004. PMID: 15218401 Review.
-
Dysfunctional HDL as a Therapeutic Target for Atherosclerosis Prevention.Curr Med Chem. 2019;26(9):1610-1630. doi: 10.2174/0929867325666180316115726. Curr Med Chem. 2019. PMID: 29546829 Review.
-
Inflammation, high-density lipoprotein and cardiovascular dysfunction.Curr Opin Infect Dis. 2011 Jun;24(3):265-72. doi: 10.1097/QCO.0b013e328344b724. Curr Opin Infect Dis. 2011. PMID: 21326098 Review.
Cited by
-
Advances in HDL: Much More than Lipid Transporters.Int J Mol Sci. 2020 Jan 22;21(3):732. doi: 10.3390/ijms21030732. Int J Mol Sci. 2020. PMID: 31979129 Free PMC article. Review.
-
Vascular consequences of inflammation: a position statement from the ESH Working Group on Vascular Structure and Function and the ARTERY Society.J Hypertens. 2020 Sep;38(9):1682-1698. doi: 10.1097/HJH.0000000000002508. J Hypertens. 2020. PMID: 32649623 Free PMC article. Review.
-
Effects of Virgin Olive Oil and Phenol-Enriched Virgin Olive Oils on Lipoprotein Atherogenicity.Nutrients. 2020 Feb 26;12(3):601. doi: 10.3390/nu12030601. Nutrients. 2020. PMID: 32110861 Free PMC article. Review.
-
A Novel Clinical Five-Risk Factor Panel for Individualized Recurrence Risk Assessment of Patients With Acute Anterior Uveitis.Transl Vis Sci Technol. 2021 Nov 1;10(13):29. doi: 10.1167/tvst.10.13.29. Transl Vis Sci Technol. 2021. PMID: 34817576 Free PMC article.
-
Systemic Hepatic-Damage Index for Predicting the Prognosis of Hepatocellular Carcinoma after Curative Resection.Front Physiol. 2017 Jul 18;8:480. doi: 10.3389/fphys.2017.00480. eCollection 2017. Front Physiol. 2017. PMID: 28769812 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical